Surrogacy Market (2026 - 2033)

Surrogacy Market Summary

The surrogacy market size was valued at USD 7.8 billion in 2025 and is projected to grow from USD 8.6 billion in 2026 to USD 17.9 billion by 2033, at a CAGR of 11.0% from 2026 to 2033. This growth is attributed to the rising prevalence of infertility, delayed parenthood, and advancements in assisted reproductive technologies (ART) such as IVF and ICSI.

Increasing infertility associated with age, lifestyle factors, medical conditions, and recurrent pregnancy loss is encouraging more individuals and couples to consider surrogacy when conventional fertility treatments are unsuccessful. At the same time, improvements in IVF, embryo culture, genetic testing, and embryo-transfer techniques are improving treatment outcomes and making gestational surrogacy more viable.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In addition, growing acceptance of single-parent and LGBTQ+ families, greater awareness of alternative family-building options, and increasing social acceptance of assisted reproduction are further expanding the potential user base.

Market Dynamics

The section below outlines the key factors driving the growth of the surrogacy market, highlighting the rising prevalence of infertility and increasing demand for assisted reproductive services among individuals and couples unable to achieve successful pregnancies naturally. It also examines the growing adoption of gestational surrogacy, advancements in In-vitro Fertilization (IVF) and embryo-transfer technologies, increasing acceptance of single-parent and LGBTQ+ family-building options, rising awareness and social acceptance of surrogacy, and improving access to fertility clinics and reproductive healthcare services.

Market Concentration & Characteristics

The surrogacy market is moderately fragmented, comprising fertility and IVF clinics, specialized surrogacy agencies, reproductive healthcare providers, and independent facilitators. Market dynamics vary across countries due to differences in regulations, reimbursement policies, eligibility criteria, and legal frameworks. Established providers benefit from strong clinical expertise, surrogate and intended-parent networks, integrated fertility services, and regulatory compliance capabilities.

The market is witnessing a high degree of innovation. Patriot Conceptions’ technology-driven approach represents an important innovation in the surrogacy market by digitizing and streamlining the traditionally fragmented surrogacy journey. The company developed a custom web application and Patriot Conceptions Fertility Support Platform (PCFSP) that integrates CRM, customer support, analytics, secure communication, and progress tracking. This innovation can reduce administrative delays, improve matching efficiency, enhance data security, expand access to surrogacy services, and provide a more personalized experience for intended parents and surrogates. Patriot Conceptions reported that its shift to virtual consultations reduced operational costs by 25% and expanded its client base by 30%, demonstrating the potential of digital technologies to improve both operational efficiency and market reach.

To learn more about this report, Download Free Sample Report

The level of merger and acquisition activities in the market can be characterized as moderate, with companies pursuing acquisitions to expand geographic reach, strengthen fertility and family-building capabilities, and integrate surrogacy into broader reproductive healthcare platforms. A notable example is Progyny’s acquisition of Apryl in June 2024. Apryl, a Berlin-based fertility benefits platform, was acquired to expand Progyny’s total fertility and family-building services across more than 100 countries. The enhanced offering includes support for fertility treatments, adoption, and surrogacy, along with access to vetted fertility clinics and country-specific benefit integration.

“Employers recognize the importance of providing fertility and family building benefits and want to be able to streamline these efforts to ensure their employees have equitable benefits and consistent high-touch experiences, regardless of where they live,”

-said Pete Anevski, CEO of Progyny. “We’re excited to broaden our support on a total scale.”

Regulations have a high impact on the market as differences in laws governing eligibility, surrogate compensation, parental rights, medical procedures, and cross-border arrangements directly influence market accessibility and provider operations. Countries such as India have established dedicated legislation, including the Surrogacy (Regulation) Act, 2021, which created national and state-level regulatory authorities and formal requirements for surrogacy arrangements. At the total level, regulations remain highly inconsistent, with some countries permitting commercial surrogacy, others allowing only altruistic arrangements, and some prohibiting surrogacy altogether.

Service expansion is an emerging strategy in the market, as providers increasingly broaden their offerings beyond basic surrogate matching to include surrogate recruitment, education, personalized support, matching, pregnancy management, compensation guidance, and postpartum care. For instance, in March 2026, ConceiveAbilities launched its “Surrogacy Spark Series,” featuring more than 20 women sharing their motivations for becoming surrogates. The initiative expands the agency’s surrogate-engagement efforts by using education and real-life experiences to attract and inform potential surrogates. ConceiveAbilities also provides individualized support throughout the journey, from matching through postpartum recovery.

"Purpose-driven women don't just dream of making a difference, they act on it," "Every surrogate we meet embodies strength, compassion, and a calling to change lives in the most extraordinary way-as featured in the new Surrogacy Spark Series."

- Michelle DeMonte, Vice President of Surrogate Engagement.

Analyst Perspective

The surrogacy market is witnessing steady growth, driven by the increasing prevalence of infertility, delayed parenthood, pregnancy-related medical conditions, and the growing acceptance of alternative family-building options. Expanding adoption of in vitro fertilization (IVF), embryo freezing, embryo transfer, genetic testing, and other assisted reproductive technologies (ART) is improving the feasibility and success of surrogacy arrangements across countries. In addition, growing acceptance of same-sex couples, single intended parents, and diverse family structures is expanding the potential user base. Continuous advancements in fertility technologies, personalized matching, digital coordination platforms, legal and financial support services, and integrated counseling are enhancing the efficiency, transparency, and accessibility of surrogacy journeys, supporting the expansion of modern surrogacy services across developed and emerging markets.

Compensation Model Insights

The commercial / compensated surrogacy segment accounted for the largest market revenue share in 2025. The growing acceptance and legalization of commercial or compensated surrogacy is supporting the expansion of the surrogacy market by creating more structured pathways for intended parents and increasing the willingness of women to become gestational carriers. In compensated arrangements, surrogates receive financial compensation in addition to reimbursement for pregnancy-related medical and ancillary expenses, which can make participation more attractive given the physical demands, time commitment, medical risks, and potential lost income associated with pregnancy.

The altruistic / uncompensated surrogacy segment is expected to register the fastest CAGR over the forecast period. This is supported by the willingness of women to help individuals or couples who are unable to carry a pregnancy, particularly when the surrogate has a close emotional relationship with the intended parents. Family members, sisters, relatives, and close friends may choose to become surrogates because they view the arrangement as an opportunity to help someone achieve parenthood, instead as a source of financial income. This motivation is supported by an October 2024 U.S. study published by NCBI, which highlights that 231 surrogates found that prosocial and altruistic motivations were primary reasons for participating in surrogacy, with participants generally having relatively stable socioeconomic circumstances. In addition, Canada provides a strong example of a regulatory environment supporting altruistic surrogacy: its Assisted Human Reproduction Act prohibits paying a surrogate a fee but permits reimbursement of eligible out-of-pocket expenses, thereby establishing a predominantly altruistic model.

Intended Parent Insights

The heterosexual couples segment accounted for the largest market revenue share of 63.8% in 2025. Heterosexual couples represent an important intended-parent segment in the surrogacy market, particularly when the female partner is unable to safely conceive or carry a pregnancy because of infertility, uterine abnormalities, recurrent pregnancy loss, or medical conditions that make pregnancy potentially life-threatening. The American Society for Reproductive Medicine (ASRM) current guidance provides a clear clinical example of a heterosexual woman who has a medical condition that makes pregnancy unsafe or impossible; in such cases, a gestational carrier can carry an IVF-created embryo on behalf of the couple. Conditions cited by ASRM include absence of the uterus, severe uterine abnormalities such as Asherman syndrome, recurrent pregnancy loss, and serious cardiovascular, renal, autoimmune, pulmonary, or other medical conditions that could make pregnancy dangerous. In addition, U.S. gestational-carrier activity has expanded considerably: SART-reported gestational-carrier cycles increased from 1,539 in 2004 to 11,515 in 2023, indicating broader utilization of this family-building pathway, although it remains a specialized segment of the overall market.

The same-sex couples segment is expected to register the fastest CAGR over the forecast period. The increasing number of same-sex couples seeking to become parents is driving demand for gestational surrogacy, egg donation, IVF, and related fertility services, particularly among male same-sex couples for whom pregnancy is biologically impossible without a gestational carrier. Greater social acceptance of LGBTQ+ families, broader recognition of same-sex parenthood, and increasing access to inclusive fertility care are encouraging more couples to pursue biological family-building options instead of adoption alone. The American Society for Reproductive Medicine (ASRM) explicitly recognizes gestational carriers as a family-building option for familial structures in which pregnancy is biologically infeasible, including single men and male same-sex couples.

Service Insights

The medical & fertility services segment dominated with the largest market share of 33.4% in 2025, due to increasing integration of medical and fertility services with surrogacy programs. Modern gestational surrogacy is closely dependent on assisted reproductive technologies (ART), particularly in-vitro fertilization (IVF), embryo creation and freezing, genetic testing, fertility medications, embryo transfer, hormonal preparation, and specialized prenatal monitoring. As fertility clinics and surrogacy providers increasingly offer these services as an integrated pathway, intended parents can access a more coordinated treatment journey from fertility assessment through embryo transfer and pregnancy management. The growth in gestational-carrier treatment is reflected in U.S. clinical activity. According to ASRM report published in May 2026, SART-reported gestational-carrier cycles increased from 1,539 in 2004 to 11,515 in 2023, demonstrating the increasing use of fertility-clinic-based medical services for surrogacy.

To learn more about this report, Download Free Sample Report

The agency, matching & coordination services segment accounted for a significant market share in the market. This is driven by the increasing complexity of surrogacy journeys and the growing preference of intended parents and surrogates for professionally managed, end-to-end support. Surrogacy involves multiple stakeholders including fertility clinics, attorneys, insurance providers, mental-health professionals, financial administrators, surrogates, and intended parents making professional coordination increasingly valuable. At the same time, agencies are placing greater emphasis on personalized and compatibility-based matching, considering factors such as personality, communication preferences, reproductive decisions, location, medical requirements, and legal considerations instead of relying solely on availability or waiting lists. For instance, ConceiveAbilities’ Matching Matters program reports a 97% success rate at the first introduction by evaluating relationship compatibility, medical criteria, legal considerations, and the preferences of both parties.

Country Insights

U.S. Surrogacy Market Trends

The U.S. surrogacy market accounted for the largest share of 52.0% in 2025, driven by the increasing infertility and medical conditions that prevent women from safely carrying a pregnancy. The CDC report published in May 2024 highlights that 19% of married U.S. women aged 15-49 with no prior births are unable to become pregnant after one year of trying, while 26% experience difficulty becoming pregnant or carrying a pregnancy to term. Moreover, the expansion of IVF is directly supporting surrogacy because modern gestational surrogacy generally relies on IVF to create an embryo that is subsequently transferred to the gestational carrier. CDC data show that 435,426 ART cycles were performed at 457 U.S. clinics in 2022, resulting in 94,039 live-birth deliveries and 98,289 live-born infants, equivalent to approximately 2.6% of all U.S. infants born that year.

Canada Surrogacy Market Trends

The Canada surrogacy market is expected to witness steady growth during the forecast period, driven by demand from individuals and couples facing infertility, same-sex couples, and intended parents seeking a regulated alternative to commercial surrogacy. Canada permits altruistic surrogacy but prohibits paying a surrogate or paying a third party to arrange surrogate services under the Assisted Human Reproduction Act. Surrogates can, however, receive reimbursement for eligible expenses such as travel, legal services, counselling, maternity clothing, healthcare-related expenses, and other specified costs. This regulatory model supports a formal surrogacy ecosystem while limiting commercialization. Market implication: demand remains supported by Canada's established fertility infrastructure and acceptance of family-building alternatives, but restrictions on compensation can constrain surrogate recruitment, thereby limiting market expansion relative to commercial surrogacy destinations.

UK Surrogacy Market Trends

The UK surrogacy market is projected to register notable growth driven by rising infertility, increasing demand from same-sex couples, and greater social acceptance of non-traditional family-building. However, the market operates under an altruistic model, with commercial surrogacy prohibited and the surrogate remaining the legal mother at birth until parenthood is transferred through a court process. Demand has nevertheless increased substantially: reporting in July 2026 indicated that almost 1,000 children were born through surrogacy in 2025, approximately twice the level recorded in 2015. The UK's Law Commissions proposed a new framework in 2023 that would provide greater clarity and allow intended parents to become legal parents from birth under specified conditions, but implementation has remained slow. Driver: rising demand combined with potential legal reform could expand the domestic market, although the existing system continues to encourage some intended parents to seek commercial arrangements overseas.

India Surrogacy Market Trends

The India surrogacy market has shifted from being a major commercial-surrogacy destination to a highly regulated altruistic-surrogacy market. The Surrogacy (Regulation) Act, 2021, prohibits commercial surrogacy and limits access to specified intended parents meeting medical and eligibility requirements. This significantly reduced the addressable market for commercial agencies and foreign intended parents. At the same time, demand remains supported by infertility, medical conditions preventing pregnancy, and India's relatively strong IVF infrastructure. In August 2026, the Himachal Pradesh High Court supported maternity leave for a woman who became a mother through surrogacy, reinforcing recognition of the rights of mothers using surrogacy.

Key Surrogacy Company Insights

The surrogacy market players are focusing on devising innovative business growth strategies in the form of service portfolio expansions, partnerships & collaborations, mergers & acquisitions, and business footprint expansions.

Key Surrogacy Companies

• CCRM Fertility

• Circle Surrogacy

• HRC Fertility Management

• TRIO Fertility

• Canadian Fertility Consulting

• ADVANCED FERTILITY CENTER CANCUN

• Surrogacy Mexico

• CReATe Fertility Centre

• Nordic Surrogacy

• INDIRA IVF

Recent Developments

• In May 2026, Pure Infusion was launched following the merger of AleraCare and Pure Healthcare, combining two established ambulatory infusion networks under a unified brand. The merger expanded outpatient infusion capabilities and strengthened the company’s ability to deliver coordinated specialty infusion care nationwide.

• In January 2026, BioMatrix Specialty Pharmacy acquired First Choice Wellness Centers to expand its ambulatory infusion services across the Southeastern U.S. The acquisition strengthened BioMatrix’s community-based infusion network and enhanced access to specialty infusion therapies through expanded outpatient care capabilities.

Surrogacy Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on industry trends in each of the segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the surrogacy market report on the basis of compensation model, intended parent, service, and country:

• Compensation Model Outlook (Revenue, USD Billion, 2021 - 2033)

  • Commercial / Compensated Surrogacy

  • Altruistic / Uncompensated Surrogacy

• Intended Parent Outlook (Revenue, USD Billion, 2021 - 2033)

  • Heterosexual Couples

  • Same-Sex Couples

  • Single Intended Parents

  • Others

• Service Outlook (Revenue, USD Billion, 2021 - 2033)

  • Medical & Fertility Services

  • Agency, Matching & Coordination Services

  • Surrogate Compensation & Reimbursements

  • Legal & Documentation Services

  • Insurance, Escrow & Financial Services

  • Counselling & Other Support Services

• Country Outlook (Revenue, USD Billion, 2021 - 2033)

  • U.S.

  • Canada

  • Mexico

  • UK

  • India

  • Australia

  • Thailand

  • Brazil

  • South Africa

  • UAE

Research Methodology

The surrogacy market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each surrogacy segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations